L. Mary Smith, Chief Development Officer at SpringWorks Therapeutics, Inc. (SWTX), sold 10,000 shares at $80.88 ($809K) on 2021-07-13, disclosed to the SEC on 2021-07-14.
Open-market sale of $809k SWTX by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SWTX | SELL | 2021-01-21 | $787K | — | Filing → |